|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 95 No. 12 (June 15), 2000:
pp. 3702-3709
Blood stem cells compared with bone marrow as a
source of hematopoietic cells for allogeneic transplantation
Richard E. Champlin,
Norbert Schmitz,
Mary M. Horowitz,
Bernard Chapuis,
Raj Chopra,
Jan
J. Cornelissen,
Robert Peter Gale,
John M. Goldman,
Fausto R. Loberiza Jr,
Bernd Hertenstein,
John P. Klein,
Emilio Montserrat,
Mei-Jie Zhang,
Olle Ringdén,
Sandra C. Tomany,
Philip A. Rowlings,
Marlies E. H. M. Van
Hoef, and
Alois Gratwohl for the IBMTR Histocompatibility
and Stem Cell Sources Working Committee and the European Group for
Blood and Marrow Transplantation (EBMT)
From the International Bone Marrow Transplant Registry, Health
Policy Institute, Medical College of Wisconsin, Milwaukee, WI, and the
European Group for Blood and Marrow Transplantation; the Section of
Blood and Marrow Transplantation, University of Texas-MD Anderson
Cancer Center, Houston, TX; Division d'Hématologie,
Hôpital Cantonal Universitaire, Geneva, Switzerland; Department
of Haematology, Glasgow Royal Infirmary, Glasgow, Scotland, United
Kingdom; The Dr Daniel den Hoed Cancer Center, Rotterdam, The
Netherlands; LRF Centre for Adult Leukaemia, Imperial College School of
Medicine, London, United Kingdom; Division of Haematology,
Kantonsspital, Basel, Switzerland; Zentrum Innere Medizin und
Dermatologie, Hannover, Germany; Postgraduate School of Hematology,
University of Barcelona, Barcelona, Spain; Department of
Transplantation Surgery, Huddinge Hospital, Huddinge, Sweden; and
Second Department of Internal Medicine, University of Kiel, Kiel,
Germany.
Peripheral blood cells are increasingly used in place of bone marrow
as a source of hematopoietic stem cells for allogeneic transplantation.
The relative efficacy of these 2 approaches is unknown. This
retrospective multivariate analysis compared results of 288 HLA-identical sibling blood stem cell transplantations with results of
536 HLA-identical sibling bone marrow transplantations. No transplants
were T-cell depleted. Median follow-up was 12 months, and analyses
focused on 1-year outcomes. Recipients of blood stem cell transplants
had more rapid recovery of neutrophils to at least
0.5 × 109/L (median time to recovery,
14 days, compared with 19 days for marrow transplants;
P < .001) and of platelets to at least
20 × 109/L (median time, 18 days, compared with 25 days
for marrow transplants; P < .001). There was no significant
difference in the incidence of grades II to IV acute graft versus host
disease (GVHD). The incidence of chronic GVHD was significantly higher
after blood stem cell transplantation (1-year probability [95%
confidence interval], 65% [56%-72%] compared with 53%
[47%-59%]; P = .02) Relapse incidence in the 2 transplant groups did not differ significantly. Treatment-related
mortality rates were lower and leukemia-free survival rates were higher
with blood stem cell transplants in patients with advanced leukemia
(acute leukemia in second remission or chronic myelogenous leukemia in
accelerated phase) but not in early leukemia (acute leukemia in first
remission or chronic myelogenous leukemia in chronic phase). The median
time from transplantation to hospital discharge was 23 days after blood
stem cell transplantation and 28 days after bone marrow transplantation
(P = .003). Further study with longer follow-up is
necessary to definitively establish the role of blood stem cells for
allogeneic transplantation, especially in patients with good-risk disease.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
T. Hahn, P. L. McCarthy Jr, M.-J. Zhang, D. Wang, M. Arora, H. Frangoul, R. P. Gale, G. A. Hale, J. Horan, L. Isola, et al.
Risk Factors for Acute Graft-Versus-Host Disease After Human Leukocyte Antigen-Identical Sibling Transplants for Adults With Leukemia
J. Clin. Oncol.,
December 10, 2008;
26(35):
5728 - 5734.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Irani, C. S. Cutler, E. E. Whang, T. E. Clancy, S. Russell, R. S. Swanson, S. W. Ashley, M. J. Zinner, and C. P. Raut
Severe Acute Gastrointestinal Graft-vs-Host Disease: An Emerging Surgical Dilemma in Contemporary Cancer Care
Arch Surg,
November 1, 2008;
143(11):
1041 - 1045.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. G. Laport, J. C. Alvarnas, J. M. Palmer, D. S. Snyder, M. L. Slovak, A. M. Cherry, R. M. Wong, R. S. Negrin, K. G. Blume, and S. J. Forman
Long-term remission of Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation from matched sibling donors: a 20-year experience with the fractionated total body irradiation-etoposide regimen
Blood,
August 1, 2008;
112(3):
903 - 909.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Tesio, L. Gammaitoni, M. Gunetti, V. Leuci, Y. Pignochino, N. Jordaney, S. Capellero, C. Cammarata, L. Caione, G. Migliaretti, et al.
Sustained Long-Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors
Stem Cells,
June 1, 2008;
26(6):
1620 - 1627.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. van Pel, H. Hagoort, M. J. Kwakkenbos, J. Hamann, and W. E. Fibbe
Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization
Haematologica,
April 1, 2008;
93(4):
601 - 604.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Stelljes, S. Hermann, J. Albring, G. Kohler, M. Loffler, C. Franzius, C. Poremba, V. Schlosser, S. Volkmann, C. Opitz, et al.
Clinical molecular imaging in intestinal graft-versus-host disease: mapping of disease activity, prediction, and monitoring of treatment efficiency by positron emission tomography
Blood,
March 1, 2008;
111(5):
2909 - 2918.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Frangoul, E. R. Nemecek, D. Billheimer, M. A. Pulsipher, S. Khan, A. Woolfrey, B. Manes, C. Cole, M. C. Walters, M. Ayas, et al.
A prospective study of G-CSF primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study
Blood,
December 15, 2007;
110(13):
4584 - 4587.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Talarn, A. Urbano-Ispizua, R. Martino, J. A. Perez-Simon, M. Batlle, C. Herrera, M. Granell, A. Gaya, M. Torrebadell, F. Fernandez-Aviles, et al.
Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome
Haematologica,
December 1, 2007;
92(12):
1655 - 1663.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Kebriaei, M. A. Detry, S. Giralt, A. Carrasco-Yalan, A. Anagnostopoulos, D. Couriel, I. F. Khouri, P. Anderlini, C. Hosing, A. Alousi, et al.
Long-term follow-up of allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning for patients with chronic myeloid leukemia
Blood,
November 1, 2007;
110(9):
3456 - 3462.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cutler, S. Li, V. T. Ho, J. Koreth, E. Alyea, R. J. Soiffer, and J. H. Antin
Extended follow-up of methotrexate-free immunosuppression using sirolimus and tacrolimus in related and unrelated donor peripheral blood stem cell transplantation
Blood,
April 1, 2007;
109(7):
3108 - 3114.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. C. Fung, M. A. Higman, and K. van Besien
Stem cell transplantation
ASH Self-Assessment Program,
January 1, 2007;
2007(1):
328 - 360.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Schmitz, M. Eapen, M. M. Horowitz, M.-J. Zhang, J. P. Klein, J. D. Rizzo, F. R. Loberiza, A. Gratwohl, and R. E. Champlin
Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation
Blood,
December 15, 2006;
108(13):
4288 - 4290.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Pene, C. Aubron, E. Azoulay, F. Blot, G. Thiery, B. Raynard, B. Schlemmer, G. Nitenberg, A. Buzyn, P. Arnaud, et al.
Outcome of Critically Ill Allogeneic Hematopoietic Stem-Cell Transplantation Recipients: A Reappraisal of Indications for Organ Failure Supports
J. Clin. Oncol.,
February 1, 2006;
24(4):
643 - 649.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. van Pel, R. van Os, G. A. Velders, H. Hagoort, P. M. H. Heegaard, I. J. D. Lindley, R. Willemze, and W. E. Fibbe
Serpina1 is a potent inhibitor of IL-8-induced hematopoietic stem cell mobilization
PNAS,
January 31, 2006;
103(5):
1469 - 1474.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Kim, Y. Kim, S. Yoon, J. Lim, M. Kim, S. Lee, S. Kang, E. J. Lee, C. S. Kang, and K. Han
Rapid Fecal Cytokeratin-19 Test and Fecal Occult Blood Test in Screening for Gastrointestinal Diseases
Ann. Clin. Lab. Sci.,
January 1, 2006;
36(3):
294 - 298.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. F. Apperley
Managing the Patient with Chronic Myeloid Leukemia Through and After Allogeneic Stem Cell Transplantation
Hematology,
January 1, 2006;
2006(1):
226 - 232.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Locatelli
Reduced-Intensity Regimens in Allogeneic Hematopoietic Stem Cell Transplantation for Hemoglobinopathies
Hematology,
January 1, 2006;
2006(1):
398 - 401.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Tauro, C. Craddock, K. Peggs, G. Begum, P. Mahendra, G. Cook, J. Marsh, D. Milligan, A. Goldstone, A. Hunter, et al.
Allogeneic Stem-Cell Transplantation Using a Reduced-Intensity Conditioning Regimen Has the Capacity to Produce Durable Remissions and Long-Term Disease-Free Survival in Patients With High-Risk Acute Myeloid Leukemia and Myelodysplasia
J. Clin. Oncol.,
December 20, 2005;
23(36):
9387 - 9393.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Rutella, F. Zavala, S. Danese, H. Kared, and G. Leone
Granulocyte Colony-Stimulating Factor: A Novel Mediator of T Cell Tolerance
J. Immunol.,
December 1, 2005;
175(11):
7085 - 7091.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Crawley, R. Szydlo, M. Lalancette, A. Bacigalupo, A. Lange, M. Brune, G. Juliusson, A. Nagler, A. Gratwohl, J. Passweg, et al.
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
Blood,
November 1, 2005;
106(9):
2969 - 2976.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Lipkin, P. Lenssen, and B. J. Dickson
Nutrition Issues in Hematopoietic Stem Cell Transplantation: State of the Art
Nutr Clin Pract,
August 1, 2005;
20(4):
423 - 439.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. H. S. Tomas, F. R. Loberiza Jr, J. P. Klein, P. M. Layde, R. J. Lipchik, J. D. Rizzo, C. N. Bredeson, and M. M. Horowitz
Risk Factors for Bronchiolitis Obliterans in Allogeneic Hematopoietic Stem-Cell Transplantation for Leukemia
Chest,
July 1, 2005;
128(1):
153 - 161.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. E. Curtis, C. Metayer, J. D. Rizzo, G. Socie, K. A. Sobocinski, M. E. D. Flowers, W. D. Travis, L. B. Travis, M. M. Horowitz, and H. J. Deeg
Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study
Blood,
May 15, 2005;
105(10):
3802 - 3811.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Remberger, D. W. Beelen, A. Fauser, N. Basara, O. Basu, and O. Ringden
Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors
Blood,
January 15, 2005;
105(2):
548 - 551.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Wysoczynski, R. Reca, J. Ratajczak, M. Kucia, N. Shirvaikar, M. Honczarenko, M. Mills, J. Wanzeck, A. Janowska-Wieczorek, and M. Z. Ratajczak
Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient
Blood,
January 1, 2005;
105(1):
40 - 48.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Eapen, M. M. Horowitz, J. P. Klein, R. E. Champlin, F. R. Loberiza Jr, O. Ringden, and J. E. Wagner
Higher Mortality After Allogeneic Peripheral-Blood Transplantation Compared With Bone Marrow in Children and Adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry
J. Clin. Oncol.,
December 15, 2004;
22(24):
4872 - 4880.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Stone
Optimizing Treatment of Chronic Myeloid Leukemia: A Rational Approach
Oncologist,
June 1, 2004;
9(3):
259 - 270.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Bornhauser, R. Schwerdtfeger, H. Martin, K.-H. Frank, C. Theuser, G. Ehninger, F. Locatelli, A. Velardi, and S. Giebel
Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors
Blood,
April 1, 2004;
103(7):
2860 - 2861.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. M. Stone, M. R. O'Donnell, and M. A. Sekeres
Acute Myeloid Leukemia
Hematology,
January 1, 2004;
2004(1):
98 - 117.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Mohty, J.-O. Bay, C. Faucher, B. Choufi, K. Bilger, O. Tournilhac, N. Vey, A.-M. Stoppa, D. Coso, C. Chabannon, et al.
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen
Blood,
July 15, 2003;
102(2):
470 - 476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Reca, D. Mastellos, M. Majka, L. Marquez, J. Ratajczak, S. Franchini, A. Glodek, M. Honczarenko, L. A. Spruce, A. Janowska-Wieczorek, et al.
Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1
Blood,
May 15, 2003;
101(10):
3784 - 3793.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Finke, C. Schmoor, H. Lang, K. Potthoff, and H. Bertz
Matched and Mismatched Allogeneic Stem-Cell Transplantation From Unrelated Donors Using Combined Graft-Versus-Host Disease Prophylaxis Including Rabbit Anti-T Lymphocyte Globulin
J. Clin. Oncol.,
February 1, 2003;
21(3):
506 - 513.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Cottler-Fox, T. Lapidot, I. Petit, O. Kollet, J. F. DiPersio, D. Link, and S. Devine
Stem Cell Mobilization
Hematology,
January 1, 2003;
2003(1):
419 - 437.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Roelofs, E. S. D. de Pauw, A. H. Zwinderman, S. M. Opdam, R. Willemze, H. J. Tanke, and W. E. Fibbe
Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation
Blood,
January 1, 2003;
101(1):
358 - 362.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. Ringden, M. Labopin, A. Bacigalupo, W. Arcese, U.W. Schaefer, R. Willemze, H. Koc, D. Bunjes, E. Gluckman, V. Rocha, et al.
Transplantation of Peripheral Blood Stem Cells as Compared With Bone Marrow From HLA-Identical Siblings in Adult Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
J. Clin. Oncol.,
December 15, 2002;
20(24):
4655 - 4664.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Dominietto, T. Lamparelli, A. M. Raiola, M. T. Van Lint, F. Gualandi, G. Berisso, S. Bregante, C. di Grazia, M. Soracco, A. Pitto, et al.
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation
Blood,
December 1, 2002;
100(12):
3930 - 3934.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Rocha, M. Labopin, E. Gluckman, R. Powles, W. Arcese, A. Bacigalupo, J. Reiffers, A. Iriondo, O. Ringden, T. Ruutu, et al.
Relevance of Bone Marrow Cell Dose on Allogeneic Transplantation Outcomes for Patients With Acute Myeloid Leukemia in First Complete Remission: Results of a European Survey
J. Clin. Oncol.,
November 1, 2002;
20(21):
4324 - 4330.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Mohty, M. Kuentz, M. Michallet, J.-H. Bourhis, N. Milpied, L. Sutton, J.-P. Jouet, M. Attal, P. Bordigoni, J.-Y. Cahn, et al.
Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study
Blood,
October 16, 2002;
100(9):
3128 - 3134.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Rutella, L. Pierelli, G. Bonanno, S. Sica, F. Ameglio, E. Capoluongo, A. Mariotti, G. Scambia, G. d'Onofrio, and G. Leone
Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells
Blood,
September 18, 2002;
100(7):
2562 - 2571.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Couban, D. R. Simpson, M. J. Barnett, C. Bredeson, L. Hubesch, K. Howson-Jan, T. B. Shore, I. R. Walker, P. Browett, H. A. Messner, et al.
A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies
Blood,
August 13, 2002;
100(5):
1525 - 1531.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Lapierre, A. Auperin, H. Tayebi, J. Chabod, P. Saas, M. Michalet, S. Francois, F. Garban, C. Giraud, D. Tramalloni, et al.
Increased presence of anti-HLA antibodies early after allogeneic granulocyte colony-stimulating factor-mobilized peripheral blood hematopoietic stem cell transplantation compared with bone marrow transplantation
Blood,
July 30, 2002;
100(4):
1484 - 1489.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Schmitz, M. Beksac, D. Hasenclever, A. Bacigalupo, T. Ruutu, A. Nagler, E. Gluckman, N. Russell, J. F. Apperley, N. C. Gorin, et al.
Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia
Blood,
July 18, 2002;
100(3):
761 - 767.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. D. Flowers, P. M. Parker, L. J. Johnston, A. V. B. Matos, B. Storer, W. I. Bensinger, R. Storb, F. R. Appelbaum, S. J. Forman, K. G. Blume, et al.
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial
Blood,
June 28, 2002;
100(2):
415 - 419.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Guardiola, V. Runde, A. Bacigalupo, T. Ruutu, F. Locatelli, M. A. Boogaerts, A. Pagliuca, J. J. Cornelissen, H. C. Schouten, E. Carreras, et al.
Retrospective comparison of bone marrow and granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells for allogeneic stem cell transplantation using HLA identical sibling donors in myelodysplastic syndromes
Blood,
May 29, 2002;
99(12):
4370 - 4378.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Bittencourt, V. Rocha, S. Chevret, G. Socie, H. Esperou, A. Devergie, L. Dal Cortivo, J.-P. Marolleau, F. Garnier, P. Ribaud, et al.
Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation
Blood,
April 15, 2002;
99(8):
2726 - 2733.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. H. Elmaagacli, S. Basoglu, R. Peceny, R. Trenschel, H. Ottinger, A. Lollert, V. Runde, H. Grosse-Wilde, D. W. Beelen, and U. W. Schaefer
Improved disease-free-survival after transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical unrelated donors in patients with first chronic phase chronic myeloid leukemia
Blood,
February 15, 2002;
99(4):
1130 - 1135.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Mehta, S. Singhal, C. Cutler, and J. H. Antin
Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell Transplantation: A Little Methotrexate Goes a Long Way
J. Clin. Oncol.,
January 15, 2002;
20(2):
603 - 606.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. J. Giles, A. Keating, A. H. Goldstone, I. Avivi, C. L. Willman, and H. M. Kantarjian
Acute Myeloid Leukemia
Hematology,
January 1, 2002;
2002(1):
73 - 110.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
D. Hoelzer, N. Gokbuget, O. Ottmann, C.-H. Pui, M. V. Relling, F. R. Appelbaum, J. J.M. van Dongen, and T. Szczepanski
Acute Lymphoblastic Leukemia
Hematology,
January 1, 2002;
2002(1):
162 - 192.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Morton, C. Hutchins, and S. Durrant
Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells
Blood,
December 1, 2001;
98(12):
3186 - 3191.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. T. Ho and R. J. Soiffer
The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
Blood,
December 1, 2001;
98(12):
3192 - 3204.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Zaucha, T. Gooley, W. I. Bensinger, S. Heimfeld, T. R. Chauncey, R. Zaucha, P. J. Martin, M. E. D. Flowers, J. Storek, G. Georges, et al.
CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation
Blood,
December 1, 2001;
98(12):
3221 - 3227.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Korbling and P. Anderlini
Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cells matter?
Blood,
November 15, 2001;
98(10):
2900 - 2908.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Remberger, O. Ringden, I.-W. Blau, H. Ottinger, B. Kremens, M. G. Kiehl, J. Aschan, D. W. Beelen, N. Basara, G. Kumlien, et al.
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors
Blood,
September 15, 2001;
98(6):
1739 - 1745.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. S. Joshi, J. C. Lynch, S. Z. Pavletic, S. R. Tarantolo, S. J. Pirruccello, A. Kessinger, and M. R. Bishop
Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics
Blood,
September 15, 2001;
98(6):
1963 - 1970.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cutler, S. Giri, S. Jeyapalan, D. Paniagua, A. Viswanathan, and J. H. Antin
Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis
J. Clin. Oncol.,
August 15, 2001;
19(16):
3685 - 3691.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. P. Hochberg, A. C. Chillemi, C. J. Wu, D. Neuberg, C. Canning, K. Hartman, E. P. Alyea, R. J. Soiffer, S. A. Kalams, and J. Ritz
Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults
Blood,
August 15, 2001;
98(4):
1116 - 1121.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Cutler and J. H. Antin
Peripheral Blood Stem Cells for Allogeneic Transplantation: A Review
Stem Cells,
February 1, 2001;
19(2):
108 - 117.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
W. I. Bensinger, P. J. Martin, B. Storer, R. Clift, S. J. Forman, R. Negrin, A. Kashyap, M. E.D. Flowers, K. Lilleby, T. R. Chauncey, et al.
Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers
N. Engl. J. Med.,
January 18, 2001;
344(3):
175 - 181.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Matsubara, A. Makimoto, J. Takayama, T. Higa, T. Saito, Y. Kanda, R. Tanosaki, S. Mineishi, M. Ohira, and Y. Takaue
Possible Clinical Benefits of the Use of Peripheral Blood Stem Cells Over Bone Marrow in the Allogeneic Transplantation Setting for the Treatment of Childhood Leukemia
Jpn. J. Clin. Oncol.,
January 1, 2001;
31(1):
30 - 34.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Druker, C. L. Sawyers, R. Capdeville, J. M. Ford, M. Baccarani, and J. M. Goldman
Chronic Myelogenous Leukemia
Hematology,
January 1, 2001;
2001(1):
87 - 112.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
